Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 December 2022 | Story Leonie Bolleurs | Photo Francois van Vuuren
At the opening of the Science Education Centre on the Bloemfontein Campus, were, from the left: Prof Loyisa Jita, Prof Francis Petersen, Dr Cobus van Breda, and the Honourable Dr Tate Makgoe.

“Music is liquid architecture; architecture is frozen music.” – Johann Wolfgang von Goethe.

These were the words used by Marius Coetzee of the Odeion School of Music when he introduced a colleague from the same department, Prof Anmari van der Westhuizen, before she performed a cello solo (GYÖRGY LIGETI mov1) during the opening of the Science Education Centre (Sci-Ed) on the Bloemfontein Campus of the University of the Free State (UFS).

“A worthy piece of music to celebrate a signature building,” Coetzee stated. 

The building accommodates the only science education centre in central South Africa, with its mission the advancement of innovative and effective mathematics and science teaching and learning, which is beneficial to student teachers, in-service teachers, learners, parents, and the public at large. 

During the opening of the event, the Rector and Vice-Chancellor of the UFS, Prof Francis Petersen, said universities are about interactive spaces such as the Science Education Centre. He believes it is in spaces such as these where innovations and initiatives are created to tackle science (and the world) of the future.

“We must seek more of these spaces at the UFS. We must ensure that graduates from our university have a solid discipline – that they have their basis right – to prepare them to interact and engage in a multidisciplinary fashion, because that is what the world outside requires." 

Speaking about the role of universities in society, Prof Petersen said the purpose of a university is to engage with society. “If we can’t show the public the value of what we have here, the public will ask what the value of universities is. Why do universities exist in the first place? Our role is always to look at things that we do best: our intellectual ability to understand how things work; us challenging specific things and infusing that into society. It is for this reason that we have public lectures, science centres, and other platforms, allowing society to engage with us.”

“Universities are places that evolve continuously, and this centre is an excellent example.”

Referring to the UFS’ twelve-year strategic plan, Vision 130, he said besides visibility, the university will also focus on impact. “We can only show our impact through our graduates, the knowledge that we generate, the research that we conduct, and engaging with society. This centre is all about that.”

The Honourable Dr Tate Makgoe, the MEC for Basic Education in the Free State, shared the sentiment that the impact of universities must be felt by the community. “I am inspired to know that this facility is open to the public. Government will be the main beneficiary of this science centre and we will use it profitably. Among others, I will send our Foundation Phase teachers here,” he stated. 

New UFS Science Education Centre building

The UFS officially opened the only Science Education Centre (Sci-Ed) in central South Africa on its Bloemfontein Campus.  (Photo: Francois van Vuuren.)

An aesthetic and educational added value

Dr Cobus van Breda, Manager of Sci-Ed and Programme Director of the Science-for-the-Future, an initiative hosted by the UFS Faculty of Education to address the challenge of mathematics and science teaching and learning in South Africa, said that the project had 289 884 participants between 2009 and 2022. 

He explained that this project implements mathematics and science teachers’ professional development and outreach programmes across the country.

“In order to extend its impact, it was decided to establish a Science Education Centre to not only enhance its teaching and learning programmes to student educators and in-service teachers, but also to provide a platform to include science communication and engagement with the public. Sci-Ed will be open to the public, and through outreach programmes as well as formal and non-formal visits to the centre, the community can make use of the benefits of the centre,” says Dr Van Breda.

He sees the promotion of parental and family involvement in children’s learning as a priority for Sci-Ed. “Programmes and events aimed at empowering parents and guardians to support their children will also be presented,” said Dr Van Breda.

The Science Education Centre’s main objective, he says, is to create a STEAM+ (Science, Technology, Engineering, Art, Mathematics, and related areas) environment in the South African context, where innovative and 21st century science education (Grade R to Grade 12) can thrive. “The intent of Sci-Ed is to expose, inspire, and empower users while engaging in STEAM experiences and interactive exhibits,” he added. 

Merging the old with the new

Dr Van Breda – the passion, drive, and dedication behind Sci-Ed – believes that teaching philosophy and facilities must complement each other. This resulted in the construction of the science centre, a realisation of a dream that started in 2005. 

The centre was built in three stages. Phase one of the development involved the construction of the building. An outdoor park area was created during phase two, and interactive exhibits, programmes, and events were planned, developed, and enhanced during phase three to serve the purpose of the facility. “The last part will continue for about six more months, as we want to develop authentic exhibitions that support the university’s teaching and learning philosophy,” said Dr Van Breda.

The Sci-Ed Building, designed to accommodate all the crucial elements of a modern science education centre, is an extension of the existing Winkie Direko Building. Dr Van Breda explained that the architect designed the new building to seamlessly merge with the Winkie Direko Building, which dates from an earlier era. “A conscious decision was made to use some cladding from the old building where it merges into the new facility. This architectural feature can also be seen as a metaphor for building a bright new future on sound foundations,” he said. 

With its interactive exhibits, Sci-Ed will make it possible for the numbers of students, student educators, in-service educators, learners, parents, other interest groups and the public who will enter its doors, to engage in a hands-on manner with activities, and as such experience a science principle. “Using interactive exhibits, we also hope to evoke questions that will stimulate discussion and enhance learning, especially coincidental learning,” said Dr Van Breda.

He added that Sci-Ed will also serve as a social space on campus, where all students can interact within a fun and exciting popular science environment.

Prof Loyiso Jita, Dean of the Faculty of Education, described the building as a dream come true. It is not just about the building, it is also about creating an intellectual space, both indoors and outdoors, to encourage students, staff, and the community to interact with science.

Science Education Centre (Sci-Ed)_

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept